What is Alector, Inc. (ALEC)?
Alector, Inc. is a biotechnology company engaged in the discovery and development of immuno-neurology therapies. The company focuses on harnessing the immune system to treat neurodegenerative diseases such as Alzheimer's disease and frontotemporal dementia. Alector's approach involves targeting innate immunity pathways to modulate neuroinflammation and promote brain health. Its pipeline includes multiple investigational drug candidates in various stages of development. The company collaborates with academic institutions and industry partners to advance its research and clinical programs. Alector emphasizes translational science to bridge laboratory findings with clinical applications. It operates research and development facilities dedicated to immunology and neurology. The company's mission centers on addressing unmet medical needs in neurodegenerative disorders through innovative therapeutic strategies.
Alector, Inc. Stock Price Today: Live Overview
The price today is shaped by ongoing market activity, with Alector, Inc. currently priced at $2.07. The trading range today has been between $1.98 and $2.08, showing a daily percentage change of 0%.
FAQ: Alector, Inc. (ALEC)
What is the current price of ALEC stock?
Alector, Inc.'s current price is $2.07.
Does ALEC pay dividends?
Alector, Inc. does not pay dividends.
Does ALEC have a formal corporate presence or regional headquarters in the UAE?
Alector, Inc. has no official presence in the UAE and operates through partnerships.
What is ALEC best known for?
Alector, Inc. is most famous for developing immuno-neurology therapies.
What assets are typically shown together with ALEC?
Commonly shown alongside ALEC: OneMain Holdings Inc, Invesco S&P 500 Equal Weight Energy ETF, Genprex, Inc.
Latest shares articles



